Cheng-Wen Wu, MD, PhD
Affiliations: | 1972-1980 | Albert Einstein College of Medicine, New York, New York, United States | |
| 1980-1990 | Stony Brook University, Stony Brook, NY, United States | ||
| 2001- | National Yang-Ming University, Allendale Charter Township, Taipei City, Taiwan |
Area:
Molecular BiologyWebsite:
https://www.thevalleefoundation.org/programs/vvp/cheng-wen-wu-md-phdGoogle:
"Cheng-Wen Wu"Bio:
https://www.phys.sinica.edu.tw/~tywufund/download/camp/2008/cv/cv_camp2008_ChengWenWu.pdf
http://faobmb.com/2015/11/24/08-05-2011-dr-cheng-wen-wu-receives-faobmb-medal-of-the-year-award-2011/
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| David A. Goldthwait | grad student | 1969 | Case Western | |
| (Studies with RNA polymerase.) | ||||
| Gordon G. Hammes | post-doc | 1969-1971 | Cornell | |
| Lubert Stryer | post-doc | 1971-1972 | Yale | |
Children
Sign in to add trainee| Ramesh Chandra | post-doc | SUNY Stony Brook | |
| Dipankar Chatterji | post-doc | 1983 | SUNY Stony Brook |
| Lynwood R Yarbrough | research scientist | 1973-1975 | Albert Einstein |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lin SC, Chung CH, Chung CH, et al. (2018) OCT4B mediates hypoxia-induced cancer dissemination. Oncogene |
| Hong SY, Kao YR, Lee TC, et al. (2018) Upregulation of E3 ubiquitin ligase CBLC enhances EGFR dysregulation and signaling in lung adenocarcinoma. Cancer Research |
| Lee T, Lin Y, Liu Y, et al. (2018) Abstract 5508: ANKRD52 inhibited tumor metastasis in lung adenocarcinoma Cancer Research. 78: 5508-5508 |
| Hong S, Kao Y, Lee T, et al. (2018) Abstract 3319: Epigenetic upregulation of E3 ubiquitin ligase CBLC enhances EGFR dysregulation and signaling Cancer Research. 78: 3319-3319 |
| Cheng C, Chou K, Wu C, et al. (2018) Abstract 3060: EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres through regulating HER3/ERBB3 expression as a therapeutic target against EGFR-positive non-small cell lung cancer Cancer Research. 78: 3060-3060 |
| Lin Y, Hong S, Kao Y, et al. (2018) Abstract 2642: CBLC is a potential biomarker for the susceptibility to paclitaxel in lung adenocarcinoma Cancer Research. 78: 2642-2642 |
| Lin TW, Chen MT, Lin LT, et al. (2017) TDP-43/HDAC6 axis promoted tumor progression and regulated nutrient deprivation-induced autophagy in glioblastoma. Oncotarget. 8: 56612-56625 |
| Wen KC, Sung PL, Hsieh SL, et al. (2017) α2,3-sialyltransferase type I regulates migration and peritoneal dissemination of ovarian cancer cells. Oncotarget |
| Cheng C, Chang J, Lin H, et al. (2017) Abstract 934: EGFR induces ILF3 and G9a expressions to maintain Oct4-mediated stemness property in lung cancer Cancer Research. 77: 934-934 |
| Lin Y, Liu Y, Lee T, et al. (2017) Abstract 4843: ANKRD52 inhibited tumor metastasis through dephosphorylation of PAK1 in lung adenocarcinoma Cancer Research. 77: 4843-4843 |